Patent · US Expired

Treatment of metastasis

US4751224A · kind A · utility

18Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 21, 1986
Grant dateJun 14, 1988
Priority date—
Expiry dateJan 21, 2006

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/35
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for reducing the incidence of metastasis in tumor victims without treating the primary tumor per se resides in the administration of forskolin or its analogs which are potent inhibitors of platelet aggregation. Forskolin compounds are generally defined as labdane diterpenoids having the general formula: ##STR1## These compounds may be administered alone or in combination with other inhibitors of platelet aggregation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.